Part B provides guidance on the regulatory framework for ‘low risk’ listed complementary medicines. The guidance is mainly directed at sponsors and manufacturers of listed medicines.

Information is provided on:

• ingredients and indications permitted for use in listed medicines
• legislative requirements for listed medicines
• quality of listed medicines
• guidance on how to list a medicine on the ARTG.